Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Change in Cash (2016 - 2025)

Historic Change in Cash for Acadia Healthcare Company (ACHC) over the last 16 years, with Q3 2025 value amounting to -$12.7 million.

  • Acadia Healthcare Company's Change in Cash fell 35568.5% to -$12.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.5 million, marking a year-over-year increase of 30949.21%. This contributed to the annual value of -$23.8 million for FY2024, which is 108052.81% down from last year.
  • As of Q3 2025, Acadia Healthcare Company's Change in Cash stood at -$12.7 million, which was down 35568.5% from $40.2 million recorded in Q2 2025.
  • Acadia Healthcare Company's 5-year Change in Cash high stood at $48.3 million for Q2 2023, and its period low was -$199.8 million during Q1 2021.
  • Moreover, its 5-year median value for Change in Cash was -$136000.0 (2024), whereas its average is -$13.7 million.
  • Its Change in Cash has fluctuated over the past 5 years, first plummeted by 131161.83% in 2024, then soared by 2964779.41% in 2025.
  • Over the past 5 years, Acadia Healthcare Company's Change in Cash (Quarter) stood at -$62.5 million in 2021, then soared by 106.77% to $4.2 million in 2022, then crashed by 88.61% to $482000.0 in 2023, then plummeted by 1311.62% to -$5.8 million in 2024, then tumbled by 117.95% to -$12.7 million in 2025.
  • Its Change in Cash was -$12.7 million in Q3 2025, compared to $40.2 million in Q2 2025 and $14.9 million in Q1 2025.